Epidemiology of invasive cutaneous melanoma
Open accessThe DOI matches its Crossref record; 53 of the 55 references it cites were found in a registry or an index.
Abstract
Data are presented on the current incidence of melanoma with recent and predicted future trends illustrating a likely continuing increase in incidence. Risk factors for developing melanoma are discussed, including current known melanoma susceptibility genes. Phenotypic markers of high-risk subjects include high counts of benign melanocytic naevi. Other risk factors considered include exposure to natural and artificial ultraviolet radiation, the effect of female sex hormones, socioeconomic status, occupation, exposure to pesticides and ingestion of therapeutic drugs including immunosuppressives and non-steroidal anti-inflammatory drugs. Aids to earlier diagnosis are considered, including public education, screening and use of equipment such as the dermatoscope. Finally, the current pattern of survival and mortality is described.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
Diagnostic accuracy of dermoscopy
Kittler, H., Pehamberger, H., Wolff, K., & Binder, M. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00679-4 · Cited by 1,349 · cited 1×
“Available data indicate that training in dermatoscope use improves both sensitivity and specificity of clinical diagnosis by non-expert clinicians, but without training, preoperative diagnostic accuracy is reduced [49, 50].”
BackgroundKarim-Kos, H. E., de Vries, E., Soerjomataram, I., Lemmens, V., Siesling, S., & Coebergh, J. W. W. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2007.12.015 · Cited by 754 · cited 1×
“and Estonia, and also eastern European countries such as Belarus and Serbia (Table 1), although recent data show a rise in incidence in many east European countries [2].”
BackgroundThe International Agency for Research on Cancer Working Group on artificial ultraviolet (UV) light and skin cancer (2007) · International Journal of Cancer · doi:10.1002/ijc.22453 · Cited by 561
Lindelöf, B., Sigurgeirsson, B., Gäbel, H., & Stern, R. S. (2000) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2000.03703.x · Cited by 559 · cited 1×
“Studies from Sweden and the Netherlands show no increase in melanoma incidence over that expected in these countries [37, 38], while studies from the USA and UK show a significantly increased risk, 3.”
BackgroundMelanocytic Nevi, Solar Keratoses, and Divergent Pathways to Cutaneous Melanoma
Whiteman, D. C., Watt, P., Purdie, D. M., Hughes, M. C., Hayward, N. K., & Green, A. C. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.11.806 · Cited by 449
ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma
Gudbjartsson, D. F., Sulem, P., Stacey, S. N., Goldstein, A. M., Rafnar, T., Sigurgeirsson, B., Benediktsdottir, K. R., Thorisdottir, K., Ragnarsson, R., Sveinsdottir, S. G., et al. (2008) · Nature Genetics · doi:10.1038/ng.161 · Cited by 354 · cited 1×
“The second study examined DNA samples from 2121 European melanoma patients and 40 000 controls and reported pigmentation gene variants ASIP and TYR associated with melanoma [18].”
BackgroundMC1R variants, melanoma and red hair color phenotype: A meta‐analysis
Raimondi, S., Sera, F., Gandini, S., Iodice, S., Caini, S., Maisonneuve, P., & Fargnoli, M. C. (2008) · International Journal of Cancer · doi:10.1002/ijc.23396 · Cited by 349 · cited 1×
“Subjects with red hair have a higher proportion of three MC1R variants, currently known as red-hair variants, and it has been a matter of discussion whether these variants are also more common in non-red-haired patients with sporadic melanoma [15].”
BackgroundBenign melanocytic naevi as a risk factor for malignant melanoma.
Swerdlow, A. J., English, J., MacKie, R. M., O'Doherty, C. J., Hunter, J. A., Clark, J., & Hole, D. J. (1986) · BMJ · doi:10.1136/bmj.292.6535.1555 · Cited by 344 · cited 1×
“Studies from Australasia [19], North America [20] and Europe [21] have all shown that a high count of banal melanocytic naevi is a major risk factor for sporadic melanoma.”
BackgroundSelf-citation
Research works printed but not linked: 1
- Curiel C Gomex ML Atkins T Association between use of non steroidal anti-inflammatories and of melanoma: a case control study. J Clin Oncol 2007 25 (Supp): abstract 8500
Cited by
Items 201–300 of 405
Andreucci, E., Bianchini, F., Biagioni, A., Rosso, M. D., Papucci, L., Schiavone, N., & Magnelli, L. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1463-7 · Cited by 14
“It is the sixth most common cancer in the USA and is one of the most fatal malignancies affecting young adults [1].”
BackgroundThe Curcumin Analog EF24 is Highly Active Against Chemotherapy- Resistant Melanoma Cells
He, Y., Li, W., Zhang, J., Yang, Y., Qian, Y., & Zhou, D. (2021) · Current Cancer Drug Targets · doi:10.2174/1568009621666210303092921 · Cited by 12
Kaehler, K. C., Politz, O., Henderson, D. A., Ulbrich, H., Hauschild, A., Mund, C., & Egberts, F. (2015) · Melanoma Research · doi:10.1097/cmr.0000000000000150 · Cited by 12
Self-citationThe role of lymph node ultrasound evaluation in melanoma – review of the literature.
Ungureanu, L., Jid, C. B., Candrea, E., Cosgarea, R., & Șenilă, S. C. (2016) · Medical Ultrasonography · doi:10.11152/mu.2013.2066.182.lym · Cited by 12
Quan, L., Wang, Y., Liang, J., Shi, J., Zhang, Y., & Tao, K. X. (2015) · Tumori Journal · doi:10.5301/tj.5000316 · Cited by 11
“Melanoma is a deadly skin cancer, which results from the malignant transformation of melanocytes and is characterized by rapid development, high metastasis ability, and limited efficiency of therapeutics (1, 2).”
BackgroundSonographic Criteria for Diagnosing Sentinel Node Metastases in Melanoma Patients
Ulrich, J., van Akkooi, A. C. J., Eggermont, A. M. M., & Voit, C. A. (2014) · Ultraschall in der Medizin - European Journal of Ultrasound · doi:10.1055/s-0034-1366360 · Cited by 11
Self-citationGellén, E., Janka, E. A., Tamás, I., Ádám, B., Horkay, I., Emri, G., & Remenyik, É. (2015) · Photodermatology Photoimmunology & Photomedicine · doi:10.1111/phpp.12219 · Cited by 15
“The incidence of MM is 4–19 per 100 000 individuals in Europe (4), and the incidence of NMSC is approximately 100 per 100 000 individuals (5).”
BackgroundInfluentialJúnior, R. G. D. O., Ferraz, C. A. A., de Oliveira, A. P., Araújo, E. C. D. C., Prunier, G., Beaugeard, L., Groult, H., Picot, L., Filho, E. B. D. A., Aouad, N. E., et al. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.109849 · Cited by 11
Multiple primary melanoma in the elderly
Krajewski, A. C., Hart, D. R., & Hieken, T. J. (2015) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2015.05.023 · Cited by 11
Multispectral Imaging Algorithm Predicts Breslow Thickness of Melanoma
Bozsányi, S., Varga, N. N., Farkas, K., Bánvölgyi, A., Lőrincz, K. K., Lihacova, I., Lihachev, A., Ploriņa, E. V., Bartha, Á., Jobbágy, A., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm11010189 · Cited by 15
Malignant melanomas on head/neck and foot: differences in time and latitudinal trends in Norway
Juzeniene, A., Micu, E., Porojnicu, A. C., & Moan, J. E. (2011) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2011.04162.x · Cited by 15
Athanasiadis, E. I., Antonopoulou, K., Chatzinasiou, F., Lill, C. M., Bourdakou, M. M., Sakellariou, A., Kypreou, K. P., Stefanaki, I., Εvangelou, Ε., Ioannidis, J. P. A., et al. (2014) · Database · doi:10.1093/database/bau101 · Cited by 11
Semenescu, A.-D., Moacă, E.-A., Iftode, A., Dehelean, C.-A., Antal, D., Vlase, L., Rotunjanu, S., Muntean, D., Chiriac, S. D., & Chioibaş, R. (2024) · Life · doi:10.3390/life14010112 · Cited by 16
“Generally, melanoma is developed at the skin level but rarely can occur on mucous membranes (rectum, vagina, and vulva) as well as at the ocular level, comprising the iris, choroid, and ciliary body [3].”
BackgroundMDA-19 suppresses progression of melanoma via inhibiting the PI3K/Akt pathway
Dang, N., Meng, X., Ma, S., Zhang, Q., Sun, X., Wei, J., & Huang, S. (2018) · Open Medicine · doi:10.1515/med-2018-0061 · Cited by 10
“[1] Mackie RM, Hauschild A, Eggermont AMM.”
BackgroundTung, C., Lu, Y., Kao, W., Liu, J., Lai, Y., Jiang, S., Chen, H., & Shih, T. (2020) · Journal of the Chinese Chemical Society · doi:10.1002/jccs.202000019 · Cited by 10
Fan, Y., Xiao, L., & Yu, D. (2021) · Aging · doi:10.18632/aging.203594 · Cited by 10
“SKCM is a highly aggressive and fatal cancer with poor treatment outcomes after progression [22].”
BackgroundLombrea, A., Semenescu, A.-D., Pavel, I. Z., Turks, M., Lugiņina, J., Peipiņš, U., Muntean, D., Dehelean, C. A., Dinu, Ş., & Danciu, C. (2023) · Plants · doi:10.3390/plants12061253 · Cited by 12
Hua, S., Wang, W., Yao, Z., Gu, J., Zhang, H., Zhu, J., Xie, Z., & Jiang, H. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05580-7 · Cited by 11
“The incidence of CM continues to increase, while that of many other cancers is decreasing (Miller and Mihm 2006; MacKie et al. 2009).”
BackgroundKridin, K., Hundt, J. E., Ludwig, R. J., Amber, K. T., Bitan, D. T., & Cohen, A. D. (2021) · Archives of Dermatological Research · doi:10.1007/s00403-021-02211-4 · Cited by 10
Olig2 regulates p53-mediated apoptosis, migration and invasion of melanoma cells
Lee, J. E., Ahn, S., Jeong, H., An, S., Myung, C. H., Lee, J., Hong, S. C., Kim, Y. J., Kim, J. Y., Ryu, J. H., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-87438-x · Cited by 11
Hajdarević, S., Hvidberg, L., Lin, Y., Donnelly, C., Gavin, A., Lagerlund, M., Pedersen, A. F., Rasmussen, B. H., Runesdotter, S., Vedsted, P., et al. (2015) · European Journal of Public Health · doi:10.1093/eurpub/ckv112 · Cited by 10
“MM is reported to be more common among people with higher socioeconomic status (SES), possibly related to greater opportunities for sun holidays (11).”
BackgroundOptimizing the management of cutaneous melanoma in the elderly
Tragos, C., & Hieken, T. J. (2011) · Surgery · doi:10.1016/j.surg.2011.07.054 · Cited by 10
Ozola, A., Azarjana, K., Doniņa, S., Proboka, G., Mandrika, I., Petrovska, R., Čēma, I., Heisele, O., Eņģele, L., Streinerte, B., et al. (2013) · Cancer Genetics · doi:10.1016/j.cancergen.2013.01.002 · Cited by 12
“Cutaneous melanoma has shown a steady increase in incidence in the white population in the preceding decades, and this trend is likely to continue (1).”
BackgroundTorres‐Collado, A. X., Nazarian, R., & Jazirehi, A. R. (2017) · Tumor Biology · doi:10.1177/1010428317721620 · Cited by 13
Schwartz, D. L., Martin, T., & Nasir, N. S. (2005) · Cited by 10
A new era in the treatment of melanoma: from biology to clinical practice
Márquez‐Rodas, I., Martín‐Algarra, S., Izquierdo, J. A. A., Cabello, S. C., & Martín, M. (2011) · Clinical & Translational Oncology · doi:10.1007/s12094-011-0734-6 · Cited by 11
Correlates of Sun Protection Behaviors Among Adults in Puerto Rico
Niu, Z., Tortolero‐Luna, G., Lozada, C., Heckman, C. J., & Coups, E. J. (2021) · International Journal of Behavioral Medicine · doi:10.1007/s12529-021-09991-z · Cited by 12
“Unlike the vast majority of cancers, the incidence of melanoma has been increasing over the past several decades in the US and elsewhere in the world, primarily among individuals of European ancestry [5].”
BackgroundPrognostic Parameters for the Primary Care of Melanoma Patients: What Is Really Risky in Melanoma?
Göppner, D., & Leverkus, M. (2011) · Journal of Skin Cancer · doi:10.1155/2011/521947 · Cited by 11
“of thinner tumors with a better prognosis [1].”
BackgroundE3 ubiquitin ligase HECTD2 mediates melanoma progression and immune evasion
Ottina, E., Panova, V., Doglio, L. E., Kazachenka, A., Cornish, G. H., Kirkpatrick, J. M., Attig, J., Young, G. R., Litchfield, K., Lesluyes, T., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01885-4 · Cited by 11
Nie, F., Chen, Z., Cao, C. Q., & Cen, Y. (2011) · DNA and Cell Biology · doi:10.1089/dna.2010.1198 · Cited by 8
“Melanoma has a complex etiology resulting from the interaction of intrinsic and environmental factors (Hayward 2003; Chaudru et al. , 2004; MacKie et al. , 2009; Tucker, 2009).”
Fleeman, N., Bagust, A., Boland, A., Beale, S., Richardson, M., Krishan, A., Stainthorpe, A., Abdulla, A., Kotas, E., Banks, L., et al. (2017) · PharmacoEconomics · doi:10.1007/s40273-017-0504-6 · Cited by 10
Ferreira, T., Santos, I. D. D. A. O., de Oliveira, A. F., & Ferreira, L. M. (2018) · Revista do Colégio Brasileiro de Cirurgiões · doi:10.1590/0100-6991e-20181715 · Cited by 42
Grogan, K. E., & Perry, G. H. (2020) · Evolutionary Anthropology Issues News and Reviews · doi:10.1002/evan.21825 · Cited by 9
Identification and characterization of a new potent inhibitor targeting CtBP1/BARS in melanoma cells
Filograna, A., Tito, S. D., Monte, M. L., Oliva, R., Bruzzese, F., Roca, M. S., Zannetti, A., Greco, A., Spano, D., Ayala, I., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03044-5 · Cited by 8
“Numerous genetic events have been linked to melanoma’s pathogenesis [18].”
Advances in cutaneous melanoma
Espinosa, E., Berrocal, A., Lopez-Martin, J. A., Cao, M. G., Cerezuela-Fuentes, P., Mayordomo, J. I., & Martín‐Algarra, S. (2012) · Clinical & Translational Oncology · doi:10.1007/s12094-012-0804-4 · Cited by 8
Covarelli, P., Burini, G., Barberini, F., Caracappa, D., Boselli, C., Noya, G., Castellani, E., & Rulli, A. (2013) · PubMed · Cited by 8
Dynamic clustering detection through multi‐valued descriptors of dermoscopic images
Cozza, V., Guarracino, M. R., Maddalena, L., & Baroni, A. (2011) · Statistics in Medicine · doi:10.1002/sim.4285 · Cited by 8
“At the beginning of the 21st century, melanoma remains a potentially fatal malignancy, giving rise to continuing concern especially in young adults [1].”
BackgroundFreund, L., Kjær, S. K., Guleria, S., Albieri, V., Andersen, A. N., Frederiksen, K., & Jensen, A. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.02.752 · Cited by 8
Wallace, D., Hussain, S., & Singh, S. (2011) · European Journal of Plastic Surgery · doi:10.1007/s00238-011-0628-4 · Cited by 8
“The incidence continues to climb, with a two- to threefold increase over the last few decades [2].”
BackgroundPrognostic parameters of malignant melanoma
Hamza, S. H. (2010) · Diagnostic histopathology · doi:10.1016/j.mpdhp.2010.03.015 · Cited by 8
Antiestrogen Therapy for Breast Cancer Modifies the Risk of Subsequent Cutaneous Melanoma
Huber, C., Bouchardy, C., Schaffar, R., Neyroud‐Caspar, I., Vlastos, G., Gal, F. L., Rapiti, E., & Benhamou, S. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0332 · Cited by 8
“org Cancer Prev Res; 5(1) January 2012 87”
BackgroundInfluentialTen-year Audit of Melanoma in a Central England Population*
Hardwicke, J., Brunt, A. M., Rylands, G., & Rayatt, S. S. (2011) · Acta Dermato Venereologica · doi:10.2340/00015555-1069 · Cited by 8
Lin, Y.-J., Ou, Y., Tsang, L.-C., & Lin, H. (2012) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443615.2012.721820 · Cited by 8
“Since the eff ect of ovarian hormones on melanoma pathogenesis remains a matter of controversy (MacKie et al. 2009; Kvaskoff et al. 2011), the relationship between infertility treatments, marked by elevated oestradiol levels, and melanoma has received increasing attention.”
BackgroundThe descriptive epidemiology of melanoma in Italy has changed - for the better
Bucchi, L., the Italian Melanoma Intergroup and the AIRTUM Working Group, Mancini, S., Crocetti, E., Maso, L. D., Baldacchini, F., Vattiato, R., Giuliani, O., Ravaioli, A., Zamagni, F., et al. (2023) · Italian Journal of Dermatology and Venereology · doi:10.23736/s2784-8671.23.07653-3 · Cited by 7
Holic, L. (2024) · Medical Oncology · doi:10.1007/s12032-024-02385-7 · Cited by 7
“Approximately 5–10% of melanoma patients have a family history of melanoma [10, 80].”
Unveiling Melanoma: A Deep Dive into Disparities at a Latin-American Cancer Institute
Ziegler‐Rodriguez, G., Ku, G. D. L. C., Piedra-Delgado, L., Torres-Maldonado, J., Dunstan, J. A., Cotrina, J. M., Galarreta-Zegarra, J. A., Valencia, G. G. C., Vilchez-Santillan, S., Pinillos-Portella, M., et al. (2024) · Annals of Surgical Oncology · doi:10.1245/s10434-024-15573-6 · Cited by 7
Non-coding RNAs in BRAF-mutant melanoma: targets, indicators, and therapeutic potential
Afsar, S., Syed, R. U., Khojali, W. M. A., Masood, N., Osman, M. E., Jyothi, J. S., Hadi, M. A., Khalifa, A. A. S., Aboshouk, N. A. M., Alsaikhan, H. A., et al. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03366-3 · Cited by 8
“In the twenty-first century, melanoma persists as a potentially lethal malignancy, showcasing a distinct trend compared to other tumor types, with its incidence on the rise (MacKie et al. 2009).”
Yang, J. X., Luo, G., Tuyana, S., Tong, X., Tu, Y., & Tao, J. (2016) · Dermatologic Surgery · doi:10.1097/dss.0000000000000607 · Cited by 7
Angus, L., Starmans, M. P. A., Rajicic, A., Odink, A. E., Jalving, M., Niessen, W. J., Visser, J. J., Sleijfer, S., Klein, S., & van der Veldt, A. A. M. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11040257 · Cited by 8
Melanoma Maligno Cutâneo: Estudo Retrospetivo de Sete Anos (2006-2012)
Moreira, J. A., Moreira, E., Azevedo, F., & Mota, A. (2014) · Acta Médica Portuguesa · doi:10.20344/amp.5211 · Cited by 17
“Melanoma maligno cutâneo: estudo retrospetivo, Acta Med Port 2014 Jul-Aug;27(4):480-488”
BackgroundMelanoma in Iran: a Retrospective 10-Year Study.
Ferdosi, S., Saffari, M., Eskandarieh, S., Raziyeh, R., Moghaddam, M. G., Ghanadan, A., & Shirkoohi, R. (2016) · PubMed · Cited by 7
Mormando, M., Puliani, G., Barnabei, A., Lauretta, R., Bianchini, M., Chiefari, A., Russillo, M., Cognetti, F., Romano, L., & Appetecchia, M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00471 · Cited by 7
“The worldwide incidence of melanoma has increased rapidly over the past 50 years (6).”
BackgroundInfluentialCanedo, I. F., Rivas‐Ruiz, F., Blazquez-Sanchez, N., Liébana, R. F., & de Troya-Martín, M. (2015) · Actas Dermo-Sifiliográficas · doi:10.1016/j.adengl.2015.01.004 · Cited by 6
“Furthermore, the phenotype that is typically seen in patients with melanoma----white skin, red or blonde hair, and blue eyes----indicates that high-frequency, low-penetrance genes, such as MC1R, may interact with environmental factors (and sun exposure in particular).(15) We believe that this was probably case in our…”
BackgroundBonin, S., Albano, A., di Meo, N., Gatti, A., Stinco, G., Zanconati, F., & Trevisan, G. (2015) · Radiology and Oncology · doi:10.1515/raon-2015-0039 · Cited by 7
Licata, G., Brancaccio, G., Ronchi, A., Borsari, S., Longo, C., Piana, S., Cinotti, É., Dragotto, M., Rubegni, P., Argenziano, G., et al. (2023) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19379 · Cited by 8
Brand, C. L., Hunger, R. E., & Jafari, S. M. S. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1366081 · Cited by 7
Suhonen, V., Rummukainen, J. K., Siiskonen, H., Mannermaa, A., & Harvima, I. T. (2021) · BMC Cancer · doi:10.1186/s12885-021-08879-1 · Cited by 6
“The incidence of melanoma in the Nordic countries of Europe is higher than that in the Baltic states [3, 4].”
BackgroundPerfil de Casos de Melanoma em um Hospital Universitário, 2003 a 2007
Purim, K. S. M., Sandri, C. D. O., Pinto, N. T., Sousa, R. H. S., & Maluf, E. M. C. P. (2013) · Revista Brasileira de Cancerologia · doi:10.32635/2176-9745.rbc.2013v59n2.523 · Cited by 6
Canedo, I. F., Rivas‐Ruiz, F., Blazquez-Sanchez, N., Liébana, R. F., & Martín, M. D. T. (2014) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2014.10.003 · Cited by 5
“Melanoma de extensión superficial 177 (55,1) Melanoma nodular 25 (9) Lentigo maligno melanoma 67 (20,5) Otros 50 (15,4)”
BackgroundNew strategies for melanoma immunotherapy
Umansky, V. (2012) · OncoImmunology · doi:10.4161/onci.19713 · Cited by 5
“Malignant melanoma is characterized by an aggressive clinical behavior, proclivity for distant metastasis and poor response to currently applied therapies.(1) Melanoma immunogenicity is well-documented including an identification of large numbers of melanoma-associated antigens (MAA) and development of spontaneous tum…”
BackgroundFridberg, M., Jonsson, L., Bergman, J., Nodin, B., & Jirström, K. (2012) · Biology of Sex Differences · doi:10.1186/2042-6410-3-16 · Cited by 7
“Background Malignant melanoma is an aggressive form of cancer with an increasing incidence and mortality worldwide [1].”
BackgroundRecent patterns in cutaneous melanoma descriptive epidemiology in the Slovak Republic
Ondrušová, M., Mriňáková, B., Ondruš, D., Poláková, K., & Durdík, Š. (2013) · Neoplasma · doi:10.4149/neo_2013_090 · Cited by 5
“[17] MACKIE RM, HAUSCHILD A, EGGERMONT AM Epide-”
BackgroundCancer stem cells, plasticity, and drug resistance
Lionetti, M. C., Fumagalli, M. R., & Porta, C. A. M. L. (2020) · Cancer Drug Resistance · doi:10.20517/cdr.2019.112 · Cited by 8
“Additionally, genetic alterations of telomerase reverse transcriptase promoter (TERT) and cyclin dependent kinase inhibitor 2A (CDK2A) or phosphatase and tensin homolog (PTEN) loss-of-function have been frequently observed in advanced melanoma([13-18]).”
BackgroundHu, D., Liu, Z., Chen, S., Huang, Y., Zeng, W., Wei, W., Zhang, C., Zhou, L., Chen, D., Wu, Y., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.738298 · Cited by 7
Tomas-Aragones, L., Gieler, U., & Linder, M. D. (2016) · Acta Dermato Venereologica · doi:10.2340/00015555-2497 · Cited by 6
Diversified β-2-adrenergic Receptor Expression and Action in Melanoma Cells
Janik, M., Szlęzak, D., Surman, M., Gołas, A., Lityń́ska, A., & Przybyło, M. (2017) · Anticancer Research · doi:10.21873/anticanres.11657 · Cited by 8
Preclinical study of the medicinal plants for the treatment of malignant melanoma
Aydoğmuş-Öztürk, F., Jahan, H., Öztürk, M., Günaydın, K., & Choudhary, M. I. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05671-5 · Cited by 5
The epidemiology of melanoma in young adults
Velazquez, A. I., & Brewer, J. D. (2013) · Expert Review of Dermatology · doi:10.1586/17469872.2013.844465 · Cited by 4
Explainable multimodal AI for skin lesion risk prediction via 3D imaging and clinical data
Wang, Z., Tai, M.-C., Hu, H., Yuan, H., Wang, C., Fu, H., & Zhang, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-33536-z · Cited by 6
Garandeau, D., Mrad, M., Levade, T., Perrotta, C., Andrieu‐Abadie, N., & Diab‐Assaf, M. (2015) · Springer eBooks · doi:10.1007/978-3-319-20750-6_6 · Cited by 9
“This trend is predicted to continue increasing for at least over the next two decades, with a doubling of incidence rates [ 1 , 2 ].”
BackgroundShi, F., Li, T., Shi, H., Wei, Y., Wang, J., Liu, C., & Liang, R. (2024) · Skin Research and Technology · doi:10.1111/srt.13916 · Cited by 4
Trends in the diagnosis of melanoma at a university center over time
Tschandl, P., Pehamberger, H., & Kittler, H. (2012) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2012.08043.x · Cited by 4
UV immunosuppression and cutaneous malignancies
Jou, P. C., McCormick, T. S., & Baron, E. D. (2011) · Expert Review of Dermatology · doi:10.1586/edm.10.72 · Cited by 6
The spectrum of oncogene mutations differs among melanoma subtypes
Мазуренко, Н. Н., Tsyganova, I. V., Лушникова, А. А., Ponkratova, D. A., Anurova, O. A., Ea, C., Михайлова, И. Н., & Демидов, Л. В. (2015) · Molecular Biology · doi:10.1134/s0026893315060163 · Cited by 4
“PCR products were separated by electrophoresis in agarose gels, iso lated using Wizard®PCR Preps DNA Purification System (Promega, United States), and sequenced on an ABI PRISM 3100 Avant using ABI PRISM® Big Dye™ Terminator Vol.3.1 reagents.”
BackgroundInfluentialEpidemiological Aspects of Photocarcinogenesis
Yadav, N., & Banerjee, M. (2018) · Photocarcinogenesis & Photoprotection · doi:10.1007/978-981-10-5493-8_6 · Cited by 4
JTC-801 Suppresses Melanoma Cells Growth through the PI3K‑Akt‑mTOR Signaling Pathways
Li, J., & Huang, F. (2018) · médecine/sciences · doi:10.1051/medsci/201834f102 · Cited by 4
Predicting Survival Time of Localized Melanoma Patients Using Discrete Survival Time Method
Sharaf, T., & Tsokos, C. P. (2014) · Journal of Modern Applied Statistical Methods · doi:10.22237/jmasm/1398917280 · Cited by 4
Ovarian melanoma complicating pregnancy achieved byin-vitrofertilisation
Sioulas, V. D., Panayiotides, I. G., Chrelias, C. G., Grammatikakis, I., Vaggopoulos, V., Kefala, M. A., & Kassanos, D. P. (2012) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443615.2012.727502 · Cited by 4
“Since the eff ect of ovarian hormones on melanoma pathogenesis remains a matter of controversy (MacKie et al. 2009; Kvaskoff et al. 2011), the relationship between infertility treatments, marked by elevated oestradiol levels, and melanoma has received increasing attention.”
BackgroundCDKN2A and MC1R variants found in Cypriot patients diagnosed with cutaneous melanoma
Koulermou, G., Shammas, C., Vassiliou, A., Kyriakides, T. C., Costi, C., Neocleous, V., Phylactou, L. A., & Pantelidou, M. (2017) · Journal of Genetics · doi:10.1007/s12041-017-0742-6 · Cited by 4
“Exposure to sunlight and other phenotypic factors such as the occurrence of atypical melanocytic nevi, skin and hair fairness, blue eyes and freckling seem to also play an important role (Mackie et al. 2009).”
BackgroundCharacteristic features of cutaneous melanoma in a dermatology referral centre in Tehran, Iran
Kamyab, K., Kazemi, S., Azimi, P., Azizpour, A., Ghandi, N., Pirooz, E., Noormohammadpour, P., Mirshams‐Shahshahani, M., & Daneshpazhooh, M. (2017) · Australasian Journal of Dermatology · doi:10.1111/ajd.12616 · Cited by 4
“There are few studies of the clinical and histological features of melanoma from Middle Eastern countries.(1) The Iranian population is composed of multiple ethnicities with various skin phenotypes (phototypes 1–5); however, most have darker skin characterised mainly as phototypes 3 and”
BackgroundSentinel bruising as a presentation of metastatic melanoma
Steele, L., & Yeoh, C. C. (2019) · BMJ Case Reports · doi:10.1136/bcr-2018-228114 · Cited by 4
A biomimetic optical approach to skin cancer detection
Ewing, K. J., Major, K. J., & Sanghera, J. S. (2020) · Optical Fibers and Sensors for Medical Diagnostics, Treatment, and Environmental Applications · doi:10.1117/12.2554642 · Cited by 4
“Melanoma, which accounts for an estimated 4% of skin cancer is responsible for approximately 75% of all deaths from skin cancer.(3,4) The total deaths in the United States due to melanomas and other types of skin cancers are estimated to be more than 12,000 per year.”
BackgroundPatient and health care delays in malignant melanoma
Hajdarević, S. (2012) · DiVA (Digitala Vetenskapliga Arkivet) · Cited by 4
Diagnostic efficiency of the main dermatoscopic symptoms and algorithms for detecting skin melanoma
Валерьевич, М. М., & Патрушев, А. В. (2021) · Russian Military Medical Academy Reports · doi:10.17816/rmmar64477 · Cited by 3
“В среднем меланома кожи в течение жизни развивается у каждого 50-го представителя популяции развитых стран [1, 2].”
Occupation-Induced Skin Cancer
Patel, A. N., & English, J. S. C. (2012) · Springer eBooks · doi:10.1007/978-3-642-02035-3_24 · Cited by 2
Streamlining Molecular Pathobiology of Malignant Melanoma
Pierard, G. (2016) · Journal of Clinical Research in Dermatology · doi:10.15226/2378-1726/3/3/00136 · Cited by 3
“The problem is real at the present time because CMM incidence is steadily rising worldwide [1].”
BackgroundGörig, T., Schneider, S. O., Greinert, R., Breitbart, E. W., & Diehl, K. (2017) · Photodermatology Photoimmunology & Photomedicine · doi:10.1111/phpp.12351 · Cited by 7
“For the random sampling of the participants, a multistage procedure was used: (1) a nationwide pool of landline and mobile telephone numbers was generated using the Gabler- Häder method12; (2) within the households with more than one person aged 14- 45, the study participants were selected using the next birthday meth…”
BackgroundMethodFiskville Firefighters Health Study
Glass, D. C., Sim, M. R., Pircher, S. L. M., & Monaco, A. D. (2014) · Cited by 3
Xie, Z., Wang, C., Li, L., Chen, X., Wei, G., Chi, Y., Liang, Y., Lan, L., Hong, J., & Li, L. (2022) · Open Medicine · doi:10.1515/med-2022-0587 · Cited by 3
“Malignant melanoma is a type of malignant tumor that originates from neural crest melanoma cells [1].”
BackgroundDiamantopoulos, P. T., Patavoukas, G., Garantzioti, A., Charakopoulos, E., Kyriakakis, G., Mikou, P., Benopoulou, Ο., & Gogas, H. J. (2022) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2022.12.012 · Cited by 3
A dynamical model of the immune system interaction in a melanoma
Nieto, B., Durán, M., Seoane, J. M., & Sanjuán, M. A. F. (2023) · Communications in Nonlinear Science and Numerical Simulation · doi:10.1016/j.cnsns.2023.107248 · Cited by 3
Zhang, M., Han, S., & Wang, Y. (2024) · Biomedical Materials · doi:10.1088/1748-605x/ad9dcf · Cited by 3
“In the US, there are 106 000 diagnosed cases in 2021, and the related mortality reaches a quarter of all cases [4–6].”
HSP90 Inhibitor-Based Strategies for Cancer Therapy: Advancing Toward Clinical Impact
Proia, D. A., & Bates, R. C. (2015) · Heat shock proteins · doi:10.1007/978-3-319-17211-8_15 · Cited by 3
Trojan, S., Dudzik, P., Totoń‐Żurańska, J., Laidler, P. M., & Kocemba‐Pilarczyk, K. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168848 · Cited by 3
Thyrotoxicosis With Pegylated Interferon Alfa-2b
Lowndes, S. A., Asher, R. G., & Middleton, M. R. (2010) · Archives of Dermatology · doi:10.1001/archdermatol.2010.306 · Cited by 3
“T HE INCIDENCE OF MALIGnant melanoma has been increasing rapidly in recent decades.(1) Depending on the tumor characteristics at presentation, 15% of all melanomas will metastasize, and in most cases this is an incurable situation, leading to an average life expectancy of less than 12 months.”
BackgroundConceptual Approach to Early Melanoma Detection: Models, Tools, Issues and Challenges
Damanpour, S., & Grichnik, J. M. (2015) · Melanoma Management · doi:10.2217/mmt.15.24 · Cited by 3
Association of Stress Coping Strategies with Immunological Parameters in Melanoma Patients
Trapp, E.-M., Trapp, M., Avian, A., Rohrer, P., Weissenböck, T., Kapfhammer, H., Demel, U., Linder, M., Kresse, A. E., & Richtig, E. (2014) · Acta Dermato Venereologica · doi:10.2340/00015555-2372 · Cited by 4
Lymphangiogenesis: Implications for Diagnosis, Treatment, and Prognosis in Patients With Melanoma
Pastushenko, I., Conejero, C., & Carapeto, F. J. (2014) · Actas Dermo-Sifiliográficas · doi:10.1016/j.adengl.2014.11.001 · Cited by 3
“The statistics from recent years are alarming, with a persistent increase in the incidence of melanoma in most countries, particularly in the younger population; such a situation obliges us to consider this tumor as a growing public health problem.(2) The treatment of choice for melanoma is surgical excision, which ac…”
BackgroundWang, S., Wang, Q., Zheng, J., Yan, L., Pan, Y., Jiang, D., Li, H., Liang, S., He, Z., & Chen, Q. (2025) · Archives of Dermatological Research · doi:10.1007/s00403-025-03961-1 · Cited by 2
“Skin cutaneous melanoma (SKCM) is a globally important cancer with serious impact [1, 2].”
Du, Z., Li, X., Tan, W., Wang, C., Wang, G., Wei, H., Pan, Y., Wu, S., Zhou, Q., & Lin, H. (2025) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s555090 · Cited by 4
“21,22 Our study indicates that the burden of disease in high SDI regions has decreased over the past decade.”
Metadata
- Authors
- MacKie, R. M., Hauschild, A., & Eggermont, A. M. M.
- Affiliations
- University of Glasgow (GB)
- Christian-Albrechts-Universität zu Kiel (DE)
- Erasmus MC (NL)
- Corresponding author
- MacKie, R.M.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2009-08
- Volume
- 20
- Pages
- vi1-vi7
- ISSN
- 0923-7534 (ISSN-L)
- PMC
- PMC2712590
- OpenAlex
- W2138414111
- Cited by
- 405
- References
- 55
- Citations by year
- 2026: 5 · 2025: 13 · 2024: 14 · 2023: 11 · 2022: 15 · 2021: 37 · 2020: 19 · 2019: 22 · 2018: 17 · 2017: 18 · 2016: 23 · 2015: 37 · 2014: 32 · 2013: 34 · 2012: 38
- FWCI
- 3.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc/4.0/ (vor, 3800 d)
- Locations
- Annals of Oncology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
- Keywords
- cutaneous melanoma, melanoma incidence, incidence trends, risk factors, melanoma susceptibility genes, UV exposure, sex hormones, socioeconomic status, occupational exposure, pesticide exposure, immunosuppressants, nonsteroidal anti-inflammatory drugs, melanoma screening, dermoscopy, melanoma survival, melanoma mortality
- MeSH terms
- Humans, Melanoma, Neoplasm Invasiveness, Risk Factors, Skin Neoplasms, Global Health, Survival Rate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.